Washington University in St. Louis (WU)

Jonathan R. Silva, PhD

Kessler Career Development Associate Professor

We want to develop precision approaches to arrhythmia therapy by identifying biophysical features of ion channels that predict patient drug response. http://silvalab.science

Matthew J. Silva, PhD

The Silva lab studies bone. We are focused on two main questions. 1) How does mechanical loading (e.g., weight-bearing exercise) stimulate bone formation and increase bone mass? 2) How do bones heal ...

Jessica M. Silva-Fisher, PhD

Identifying and characterizing regulatory RNAs in multiple myeloma and breast cancer using advanced next generation sequencing and molecular methods.

Michelle I. Silver, PhD, ScM, Other

My research interests center around applied/translational epidemiology and health services research, and how to best use the results of epidemiologic studies to make and implement evidence-based ...

Gary A. Silverman, MD, PhD

Harriet B. Spoehrer Professor and Chairman, Department of Pediatrics

Life threatening human diseases drastically alter cellular homeostasis triggering cellular dysfunction, tissue damage, and death. Proteases are the major executioners of cell death, and are blocked, ...

Julie M. Silverstein, MD

Associate Professor of Medicine

Pituitary tumors

Matthew L. Silviera, MD

Colon and rectal surgery quality improvement, delivery of rectal cancer therapy

Srikanth Singamaneni, PhD

Lilyan and E. Lisle Hughes Professor

I am primarily interested in the application of plasmonics in nanomedicine. I am involved in the development of plasmonic biosensors for label-free detection of biomarkers, which enables early ...

Jasvindar Singh, MD

Professor of Medicine

1. Outcome and Pharmacology research in interventional cardiology 2. New approach to restenosis in coronary arteries using anti-inflammatory and anti smooth muscle proliferating drugs with special ...

Nathan Singh, MD, MS

Our laboratory is interested in understanding the molecular pathways that regulate the success and failure of engineered T cell therapies for cancer. Through investigation of the interactions between ...